ArticleNanomedicine (London, England)2024
Novel Tubeimoside I liposomal drug delivery system in combination with gemcitabine for the treatment of pancreatic cancer.
Shuhui Li, Yuansheng Liu, Xiaojun Sui, Yuzhen Zhuo, He Siqi, Zhang Sijia, Zhang Hui, Li Dihua, Zhang Dapeng, Yang Lei
Abstract read
In one paragraphArticle in Nanomedicine (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Shuhui LiSchool of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.ORCID 0009-0001-2938-5034 Yuansheng LiuDepartment of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, 300000, China.ORCID 0000-0003-0819-8800 Xiaojun SuiTianjin Key Laboratory of Organ Injury and ITCWM Repair Associated with Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin Medical University, Tianjin, 300100, China.
Yuzhen ZhuoTianjin Key Laboratory of Organ Injury and ITCWM Repair Associated with Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin Medical University, Tianjin, 300100, China.
He SiqiGraduate School ofTianjin Medical University, Tianjin, 300270, China.
Zhang HuiTianjin Key Laboratory of Organ Injury and ITCWM Repair Associated with Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin Medical University, Tianjin, 300100, China.
Li DihuaTianjin Key Laboratory of Organ Injury and ITCWM Repair Associated with Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin Medical University, Tianjin, 300100, China.
Zhang DapengTianjin Key Laboratory of Organ Injury and ITCWM Repair Associated with Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin Medical University, Tianjin, 300100, China.
Yang LeiTianjin Key Laboratory of Organ Injury and ITCWM Repair Associated with Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin Medical University, Tianjin, 300100, China.ORCID 0000-0002-3494-8161 Funding
Science Foundation of Tianjin Municipal Health Bureau No. 2021044; No. 2021009Tianjin Key Medical Discipline Construction Project TJYXZDXK-044ATianjin Natural Science Foundation No. 18JCQNJC13400; No. 21JCZDJC00450
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
DeoxycytidineDrug Delivery SystemsGemcitabineLiposomesPancreatic NeoplasmsAnimalsAntineoplastic AgentsCell Line, TumorDrug LiberationHumansMiceParticle SizeSaponinsTriterpenesAntineoplastic AgentsDeoxycytidineGemcitabineLiposomesSaponinsTriterpenestubeimoside IF18-FDG micro-PET/CT imaginggemcitabineliposomespancreatic cancertubular alfalfa glycosides Itumor microenvironment
Identifiers
PMID39225145
PMCPMC11485868
What OpenQuestion holds
Textmetadata
Read underepoch 390